SillaJen : China’s FDA Oks To Commence Phase 3 Trial For Oncolytic Immunotherapy – Nasdaq
|
SillaJen : China’s FDA Oks To Commence Phase 3 Trial For Oncolytic Immunotherapy
Nasdaq (RTTNews.com) – SillaJen, Inc. and Lee’s Pharmaceutical Holdings Ltd. announced approval by the China Food and Drug Administration to conduct a Phase 3 clinical trial for advanced liver cancer using its oncolytic immunotherapy called Pexa-Vec (formerly … |
|
CIRM Approves $5.8 Million Grant for CAR–T Therapy That Targets Cancer Stem Cells
Newswise (press release) Newswise — The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School of Medicine researchers to develop a … |
PBS NewsHour |
Will we be wiped out by machine overlords? Maybe we need a game plan now
PBS NewsHour NICK BOSTROM: The greatest existential risks arise from certain anticipated technological breakthroughs that we might make, in particular, machine superintelligence, nanotechnology, and synthetic biology, fundamentally because we don’t have the ability … |
Sacramento Bee |
California stem cell agency researching cures for brain cancer afflicting McCain
Sacramento Bee The aggressive brain cancer that now afflicts U.S. Sen. John McCain has long been a target of California’s $3 billion stem cell agency. During its 12-year life span, the agency, formally known as the California Institute for Regenerative Medicine, or … |
Sacramento Bee |
California stem cell agency researching cures for brain cancer afflicting McCain
Sacramento Bee The aggressive brain cancer that now afflicts U.S. Sen. John McCain has long been a target of California’s $3 billion stem cell agency. During its 12-year life span, the agency, formally known as the California Institute for Regenerative Medicine, or … |
CNN |
The future of treatment for glioblastoma
CNN “There is a great deal of excitement about some of the immunotherapy-based approaches in treatment of glioblastoma,” Ahluwalia said. “Immunotherapy has been shown to be promising in a number of other cancers, like lung cancer and melanoma. We are … John McCain’s Brain Cancer vs. Jimmy Carter’s: Why Is McCain’s Prognosis Worse?Heavy.com What Do We Know about the Brain Cancer Plaguing Sen. John McCain?Scientific American Glioblastoma: Understanding the brain cancer that John McCain has been diagnosed withThe Independent Washington Post –CBS News all 1,780 news articles » |
Science News Magazine |
Resistance to CRISPR gene drives may arise easily
Science News Magazine Resistance to the tools, called CRISPR gene drives, arose at high rates in experiments with Drosophila melanogaster fruit flies, researchers at Cornell University report July 20 in PLOS Genetics. Rates of resistance varied among strains of fruit flies … Researchers Design, Construct Genome-Wide Sequence-Verified …GenomeWeb Library of CRISPR targeting sequences increases power of the gene …EurekAlert (press release) CRISPR and CRISPR-Associated (Cas) Genes Market: Shares and Strategies for Key Industry Players by 2025Digital Journal Genetic Engineering & Biotechnology News –The San Diego Union-Tribune –MTNV all 10 news articles » |
|
An All-Canadian Collaborative Synthetic Biology Project
PLoS Blogs (blog) This is the second article of a series of three in which I will be speaking about Canadian initiatives in synthetic biology. In my previous post I talked about Amino Bio, a startup company ‘pioneering accessible bioengineering in the home and school … |